Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 851 to 900 of 2003

TitleReference numberPublishedLast updated
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Transcranial magnetic stimulation for obsessive-compulsive disorderIPG676
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseIPG677
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Artificial iris insertion for acquired aniridiaIPG674
Artificial iris insertion for congenital aniridiaIPG675
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaMTG49
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)DG39
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Generalised anxiety disorder and panic disorder in adults: managementCG113
Intravenous fluid therapy in children and young people in hospitalNG29
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632
Joint replacement (primary): hip, knee and shoulderNG157
Larotrectinib for treating NTRK fusion-positive solid tumoursTA630
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancerTA628
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximabTA629
PneuX to prevent ventilator-associated pneumoniaMTG48
Lenalidomide with rituximab for previously treated follicular lymphomaTA627
Abdominal aortic aneurysm: diagnosis and managementNG156
Tinnitus: assessment and managementNG155
Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapseIPG669
Cyanoacrylate glue occlusion for varicose veinsIPG670
MRI-guided laser interstitial thermal therapy for drug-resistant epilepsyIPG671
Selective internal radiation therapy for unresectable colorectal metastases in the liverIPG672
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal)TA625
Impetigo: antimicrobial prescribingNG153
Neonatal parenteral nutritionNG154
SepsiTest assay for rapidly identifying bloodstream bacteria and fungiDG20
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosisTA624
Patiromer for treating hyperkalaemiaTA623
Sotagliflozin with insulin for treating type 1 diabetesTA622
Antenatal and postnatal mental health: clinical management and service guidanceCG192
Episcissors-60 for mediolateral episiotomyMTG47
Leg ulcer infection: antimicrobial prescribingNG152
Fetoscopic prenatal repair for open neural tube defects in the fetusIPG667
Open prenatal repair for open neural tube defects in the fetusIPG668
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissuesIPG666
Supporting adult carersNG150
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and CMTG27
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)TA618
Indoor air quality at homeNG149
Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA617

Results per page

  1. 10
  2. 25
  3. 50
  4. All